Biotech Acquisition Co - Warrants (30/11/2027)'s receivables is $0.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Biotech Acquisition Co - Warrants (30/11/2027) (BIOTW) currently reports a receivables of $0 as of September 2022. In the prior-year period, the figure was $0. Use the charts on this page to explore Biotech Acquisition Co - Warrants (30/11/2027)'s receivables history and peer comparisons.
Biotech Acquisition Co - Warrants (30/11/2027)'s receivables changed from $0 to $0 (period ending September 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Biotech Acquisition Co - Warrants (30/11/2027) reported $0 in receivables as of September 2022. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current receivables of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Biotech Acquisition Co - Warrants (30/11/2027), and consider following BIOTW for alerts when major investors trade the stock.